ATS 2018 International Conference

Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-Exacerbations in Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients (PII116678)

Location: PRE-FUNCTION 5-6

Session Type: Mini Symposium

Wednesday

May

11:00 AM

11:15 AM

Speaker(s)/Author(s)

Emily Jarvis

MSc
GlaxoSmithKline

Claudia Leemereise

MSc
Glaxosmithkline

Edith Hessel

PhD
Glaxosmithkline

J. Nicole Hamblin

PhD
Glaxosmithkline

Anthony Cahn

MD
GlaxoSmithKline

Robert Wilson

PhD
GlaxoSmithKline

Yi Cui

PhD
Glaxosmithkline

Mickael Montembault

PhD
Glaxosmithkline

Maki Mizuma

PhD
Glaxosmithkline

Jon Robertson

PhD
GlaxoSmithKline

Cedric Van Holsbeke

PhD
FLUIDDA;FLUIDDA NV

Jan De Backer

MSc, PhD
FLUIDDA;FLUIDDA NV

Malcolm Begg

PhD
Glaxosmithkline

View Abstract

Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-Exacerbations in Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients (PII116678)

Parent Sessions

D12 - IMMUNOTHERAPY IN LUNG DISEASE...
05-23-2018 9:15 AM - 11:15 AM

Event

Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-Exacerbations in Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients (PII116678)

Speaker(s)/Author(s)

Emily Jarvis

Claudia Leemereise

Edith Hessel

J. Nicole Hamblin

Anthony Cahn

Robert Wilson

Yi Cui

Mickael Montembault

Maki Mizuma

Jon Robertson

Cedric Van Holsbeke

Jan De Backer

Malcolm Begg

View Abstract

Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-Exacerbations in Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients (PII116678)

Parent Sessions